Table 4.
Effect of different factors on statin expenditure changes*
| 2005 | 2006 | 2007 | 2008 | 2009 | Average | |
|---|---|---|---|---|---|---|
| Year-on-year increased statin expenditure rate (%)* (T) |
|
35.92 |
26.90 |
11.60 |
14.99 |
21.97 |
|
Core medicines (year-to-year rates of increase: %, A) |
|
46.62 |
23.61 |
2.32 |
14.17 |
18.24 |
| - Price (△P) |
|
−7.18 |
−0.33 |
−0.22 |
−6.21 |
−2.98 |
| -Within-component mix (generic mix) |
|
5.36 |
−2.12 |
−1.77 |
−2.06 |
−0.90 |
| -Between-component mix |
|
4.54 |
0.83 |
0.10 |
1.19 |
1.36 |
| (Ingredient mix) | ||||||
| - Volume (△Q) |
|
47.94 |
32.21 |
5.04 |
21.58 |
23.48 |
|
New entrants (year-to-year rates of increase: %, B) |
|
2.69 |
3.30 |
10.54 |
0.96 |
6.43 |
| - New molecular entities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| - New medicines |
|
0.00 |
0.00 |
0.01 |
0.34 |
0.12 |
| - New generic medicines |
|
1.87 |
3.23 |
10.53 |
0.30 |
5.13 |
| - Others |
|
0.82 |
0.07 |
0.00 |
0.32 |
0.26 |
| Exiting medicines (year-to-year rates of increase: %, C) | −13.39 | 0.00 | −1.26 | −0.14 | −2.70 |
*The drug expenditure was adjusted for inflation.